You are here

Article Text

Article menu
Download PDFPDF
Case report
Severe neonatal pulmonary artery hypertension rescued with vasopressin
  1. Ankit Ranjan,
  2. Venkataseshan Sundaram,
  3. Manish Taneja and
  4. Sourabh Dutta
  1. Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India
  1. Correspondence to Dr Venkataseshan Sundaram; venkatpgi{at}gmail.com

Abstract

An inborn term neonate weighing 2600 g developed meconium aspiration syndrome at birth. Baby had respiratory failure requiring high-frequency oscillatory ventilation support at 15 hours of life. He additionally developed hypotension with left ventricular dysfunction noted on point-of-care echocardiography (POCE), which required dopamine and epinephrine infusions. At 28 hours of life, he was started on inhaled nitric oxide (iNO), followed by milrinone due to hypoxaemic respiratory failure and the POCE revealed severe pulmonary artery hypertension (PAH). As PAH was refractory to iNO and milrinone, vasopressin was added which resulted in rapid improvement in oxygenation and normalisation of pulmonary artery pressures. Baby was weaned off from vasoactive support in the next 120 hours. Vasopressin proved to be the rescue agent in this case of iNO refractory PAH without any side effects during therapy. Baby was successfully extubated on day 18 and was discharged with a normal neurological examination finding.

  • pulmonary hypertension
  • neonatal and paediatric intensive care
  • neonatal health

https://doi.org/10.1136/bcr-2020-240360

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors AR and MT managed the case, VS and SD supervised the clinical management. AR drafted the manuscript, VS and SD critically reviewed and revised the manuscript. All authors approved the final version and shall be responsible for all aspects of the work.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.